TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 1,148,777,709
- Total 13F shares
- 595,232,782
- Share change
- -4,582,206
- Total reported value
- $29,899,759,479
- Put/Call ratio
- 63%
- Price per share
- $50.23
- Number of holders
- 803
- Value change
- -$270,337,135
- Number of buys
- 339
- Number of sells
- 371
Quarterly Holders Quick Answers
What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 881624209:
Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.8%
|
77,936,856
|
$4,170,401,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.2%
|
36,821,959
|
$1,970,348,000 | — | 31 Mar 2016 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.9%
|
32,971,622
|
$1,764,311,000 | — | 31 Mar 2016 | |
| PAULSON & CO. INC. |
13F
|
Company |
1.8%
|
20,602,200
|
$1,102,424,000 | — | 31 Mar 2016 | |
| Invesco Ltd. |
13F
|
Company |
1.6%
|
18,905,926
|
$1,011,656,000 | — | 31 Mar 2016 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.6%
|
18,462,435
|
$987,925,000 | — | 31 Mar 2016 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
1.3%
|
14,464,036
|
$773,970,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
12,895,697
|
$690,048,000 | — | 31 Mar 2016 | |
| NORGES BANK |
13F
|
Company |
1%
|
11,879,795
|
$635,688,000 | — | 31 Mar 2016 | |
| Capital Research Global Investors |
13F
|
Company |
1%
|
11,543,300
|
$617,682,000 | — | 31 Mar 2016 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.97%
|
11,176,001
|
$598,028,000 | — | 31 Mar 2016 | |
| HIGHFIELDS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.83%
|
9,591,150
|
$513,222,000 | — | 31 Mar 2016 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
0.81%
|
9,315,460
|
$498,471,000 | — | 31 Mar 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.77%
|
8,806,615
|
$471,242,000 | — | 31 Mar 2016 | |
| PointState Capital LP |
13F
|
Company |
0.72%
|
8,272,578
|
$442,666,000 | — | 31 Mar 2016 | |
| Sculptor Capital LP |
13F
|
Company |
0.7%
|
8,048,306
|
$430,665,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.67%
|
7,731,884
|
$413,733,000 | — | 31 Mar 2016 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.62%
|
7,140,628
|
$382,096,000 | — | 31 Mar 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.6%
|
6,837,867
|
$365,894,000 | — | 31 Mar 2016 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.56%
|
6,404,746
|
$342,718,000 | — | 31 Mar 2016 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.51%
|
5,892,802
|
$315,323,000 | — | 31 Mar 2016 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.5%
|
5,801,263
|
$310,426,000 | — | 31 Mar 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.49%
|
5,606,391
|
$299,997,000 | — | 31 Mar 2016 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
5,579,312
|
$298,549,000 | — | 31 Mar 2016 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.48%
|
5,536,567
|
$296,179,000 | — | 31 Mar 2016 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.46%
|
5,279,393
|
$287,199,000 | — | 31 Mar 2016 | |
| INSTITUTIONAL CAPITAL LLC |
13F
|
Company |
0.46%
|
5,310,234
|
$284,151,000 | — | 31 Mar 2016 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.46%
|
5,272,805
|
$282,148,000 | — | 31 Mar 2016 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.46%
|
5,231,135
|
$279,918,000 | — | 31 Mar 2016 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
5,127,907
|
$274,394,000 | — | 31 Mar 2016 | |
| Boston Partners |
13F
|
Company |
0.39%
|
4,518,391
|
$241,779,000 | — | 31 Mar 2016 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
0.39%
|
4,482,801
|
$239,875,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
4,080,416
|
$218,342,000 | — | 31 Mar 2016 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.35%
|
4,032,857
|
$215,799,000 | — | 31 Mar 2016 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
0.35%
|
4,008,853
|
$214,521,000 | — | 31 Mar 2016 | |
| Blue Ridge Capital, L.L.C. |
13F
|
Company |
0.35%
|
3,988,300
|
$213,414,000 | — | 31 Mar 2016 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
0.34%
|
3,872,699
|
$207,228,000 | — | 31 Mar 2016 | |
| FIR TREE CAPITAL MANAGEMENT LP |
13F
|
Company |
0.32%
|
3,691,929
|
$197,555,000 | — | 31 Mar 2016 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.31%
|
3,601,326
|
$192,707,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.3%
|
3,491,587
|
$186,835,000 | — | 31 Mar 2016 | |
| BlackRock Group LTD |
13F
|
Company |
0.3%
|
3,441,894
|
$184,176,000 | — | 31 Mar 2016 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.27%
|
3,120,178
|
$166,961,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
3,029,954
|
$162,133,000 | — | 31 Mar 2016 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.26%
|
3,015,673
|
$161,368,000 | — | 31 Mar 2016 | |
| RUSSELL FRANK CO/ |
13F
|
Company |
0.26%
|
3,012,076
|
$161,224,000 | — | 31 Mar 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
2,762,583
|
$147,825,000 | — | 31 Mar 2016 | |
| Senator Investment Group LP |
13F
|
Company |
0.24%
|
2,750,000
|
$147,152,000 | — | 31 Mar 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.23%
|
2,696,000
|
$144,263,000 | — | 31 Mar 2016 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.23%
|
2,660,541
|
$142,366,000 | — | 31 Mar 2016 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.23%
|
2,596,813
|
$138,955,000 | — | 31 Mar 2016 |
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2016
As of 30 Jun 2016,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
803 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
595,232,782 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, Viking Global Investors LP, BARROW HANLEY MEWHINNEY & STRAUSS LLC, WADDELL & REED FINANCIAL INC, Capital Research Global Investors, PAULSON & CO. INC., LAZARD ASSET MANAGEMENT LLC, PointState Capital LP, and Bank of New York Mellon Corp.
This page lists
803
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
827
Q2 2016 holders
803
Holder diff
-24
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.